IP Verse

Redirected, Genetically-Engineered T Regulatory Cells And Their Use In Suppression Of Autoimmune And Inflammatory Disease

Patent No. EP3097923 (titled "Redirected, Genetically-Engineered T Regulatory Cells And Their Use In Suppression Of Autoimmune And Inflammatory Disease") was filed by Yeda Research on Jan 31, 2008. The application was issued on Jul 27, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JG OPPOSITIONSApr 27, 2023GREGSON

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3097923

YEDA RESEARCH
Application Number
EP16177278A
Filing Date
Jan 31, 2008
Status
Granted And Under Opposition
Jun 24, 2022
Publication Date
Jul 27, 2022
External Links
Slate, Register , Google Patents